Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Anti-cancer activity of a novel palladium(II) complex on human breast cancer cells in vitro and in vivo.

Ulukaya E, Ari F, Dimas K, Ikitimur EI, Guney E, Yilmaz VT.

Eur J Med Chem. 2011 Oct;46(10):4957-63. doi: 10.1016/j.ejmech.2011.07.055. Epub 2011 Aug 5.

PMID:
21885165
2.

Apoptosis-inducing effect of a palladium(II) saccharinate complex of terpyridine on human breast cancer cells in vitro and in vivo.

Ari F, Cevatemre B, Armutak EI, Aztopal N, Yilmaz VT, Ulukaya E.

Bioorg Med Chem. 2014 Sep 1;22(17):4948-54. doi: 10.1016/j.bmc.2014.06.039. Epub 2014 Jun 26.

PMID:
25047941
3.

Palladium(II) saccharinate complexes with bis(2-pyridylmethyl)amine induce cell death by apoptosis in human breast cancer cells in vitro.

Ari F, Ulukaya E, Sarimahmut M, Yilmaz VT.

Bioorg Med Chem. 2013 Jun 1;21(11):3016-21. doi: 10.1016/j.bmc.2013.03.073. Epub 2013 Apr 6.

PMID:
23601820
4.

Anticancer effect of a novel palladium-saccharinate complex of terpyridine by inducing apoptosis on Ehrlich ascites carcinoma (EAC) in Balb-C mice.

Ikitimur-Armutak EI, Sonmez K, Akgun-Dar K, Sennazli G, Kapucu A, Yigit F, Yilmaz VT, Ulukaya E.

Anticancer Res. 2015 Mar;35(3):1491-7.

PMID:
25750302
5.

Biochemical and proteomic analysis of a potential anticancer agent: Palladium(II) Saccharinate complex of terpyridine acting through double strand break formation.

Adiguzel Z, Baykal AT, Kacar O, Yilmaz VT, Ulukaya E, Acilan C.

J Proteome Res. 2014 Nov 7;13(11):5240-9. doi: 10.1021/pr5006718. Epub 2014 Sep 11.

PMID:
25210790
6.

Promising anti-growth effects of palladium(II) saccharinate complex of terpyridine by inducing apoptosis on transformed fibroblasts in vitro.

Coskun MD, Ari F, Oral AY, Sarimahmut M, Kutlu HM, Yilmaz VT, Ulukaya E.

Bioorg Med Chem. 2013 Aug 1;21(15):4698-705. doi: 10.1016/j.bmc.2013.05.023. Epub 2013 May 23.

PMID:
23751940
7.

Evaluation of the molecular mechanisms of a palladium(II) saccharinate complex with terpyridine as an anticancer agent.

Kacar O, Adiguzel Z, Yilmaz VT, Cetin Y, Cevatemre B, Arda N, Baykal AT, Ulukaya E, Acilan C.

Anticancer Drugs. 2014 Jan;25(1):17-29. doi: 10.1097/CAD.0b013e328364c6ad.

PMID:
24045367
8.

Apoptosis-inducing Effect of a Palladium(II) Complex-[PdCl(terpy)](sac).2H2O] on Ehrlich Ascites Carcinoma (EAC) in Mice.

Ikitimur-Armutak EI, Ulukaya E, Gurel-Gurevin E, Yaylim I, Isbilen-Basok B, Sennazli G, Yuzbasioglu-Ozturk G, Sonmez K, Celik F, Kucukhuseyin O, Korkmaz G, Yilmaz VT, Zeybek SU.

In Vivo. 2016 Jul-Aug;30(4):457-64.

PMID:
27381609
9.

Biologic activity of a dinuclear Pd(II)-spermine complex toward human breast cancer.

Fiuza SM, Holy J, Batista de Carvalho LA, Marques MP.

Chem Biol Drug Des. 2011 Jun;77(6):477-88. doi: 10.1111/j.1747-0285.2011.01081.x. Epub 2011 Apr 1.

PMID:
21371266
10.

Synthesis, structural characterization and cell death-inducing effect of novel palladium(II) and platinum(II) saccharinate complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine on cancer cells in vitro.

Ari F, Aztopal N, Icsel C, Yilmaz VT, Guney E, Buyukgungor O, Ulukaya E.

Bioorg Med Chem. 2013 Nov 1;21(21):6427-34. doi: 10.1016/j.bmc.2013.08.050. Epub 2013 Sep 3.

PMID:
24054490
11.

Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling.

Park SK, Sanders BG, Kline K.

Breast Cancer Res Treat. 2010 Nov;124(2):361-75. doi: 10.1007/s10549-010-0786-2. Epub 2010 Feb 16.

PMID:
20157774
12.

Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis.

Tsai SL, Suk FM, Wang CI, Liu DZ, Hou WC, Lin PJ, Hung LF, Liang YC.

Biochem Pharmacol. 2007 Dec 3;74(11):1575-86. Epub 2007 Aug 11.

PMID:
17869226
13.

Seleno-cyclodextrin sensitises human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression.

Lin T, Ding Z, Li N, Xu J, Luo G, Liu J, Shen J.

Eur J Cancer. 2011 Aug;47(12):1890-907. doi: 10.1016/j.ejca.2011.04.004. Epub 2011 May 10.

PMID:
21565489
14.

Anti-metastatic and anti-angiogenic properties of potential new anti-cancer drugs based on metal complexes of selenosemicarbazones.

Zec M, Srdic-Rajic T, Konic-Ristic A, Todorovic T, Andjelkovic K, Filipovic-Ljeskovic I, Radulovic S.

Anticancer Agents Med Chem. 2012 Nov;12(9):1071-80.

PMID:
22583413
15.

Cytotoxic activity of novel palladium-based compounds on leukemia cell lines.

Antunovic M, Kriznik B, Ulukaya E, Yilmaz VT, Mihalic KC, Madunic J, Marijanovic I.

Anticancer Drugs. 2015 Feb;26(2):180-6. doi: 10.1097/CAD.0000000000000174.

PMID:
25280061
16.

Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.

Qamar S, Carrasquer CA, Cunningham SL, Cunningham AR.

Anticancer Res. 2011 Oct;31(10):3247-52.

PMID:
21965732
17.

Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.

Matsumoto G, Namekawa J, Muta M, Nakamura T, Bando H, Tohyama K, Toi M, Umezawa K.

Clin Cancer Res. 2005 Feb 1;11(3):1287-93.

18.

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.

Shi YK, Li ZH, Han XQ, Yi JH, Wang ZH, Hou JL, Feng CR, Fang QH, Wang HH, Zhang PF, Wang FS, Shen J, Wang P.

Cancer Chemother Pharmacol. 2010 Nov;66(6):1131-40. doi: 10.1007/s00280-010-1455-1. Epub 2010 Sep 14.

PMID:
20838997
19.
20.

Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand.

Gao E, Liu L, Zhu M, Huang Y, Guan F, Gao X, Zhang M, Wang L, Zhang W, Sun Y.

Inorg Chem. 2011 Jun 6;50(11):4732-41. doi: 10.1021/ic102142j. Epub 2011 Apr 26.

PMID:
21520903

Supplemental Content

Support Center